GLAXF - GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q3 2021 Results - Earnings Call Transcript
GlaxoSmithKline plc (GSK) Q3 2021 Earnings Conference Call October 27, 2021, 09:00 AM ET Company Participants Emma Walmsley – CEO Nick Stone – Head of Investor Relations Brian McNamara – CEO of GSK Consumer Healthcare Iain Mackay – CFO Hal Barron – Chief Scientific Officer Roger Connor – President of GSK David Redfern – Chief Strategy Officer Deborah Waterhouse – CEO of ViiV Healthcare Luke Miels – Chief Commercial Officer Conference Call Participants James Gordon – JP Morgan Peter Holford – Jefferies Mark Purcell – Morgan Stanley Simon Martha – Exane Graham Parry – Bank of America Seamus Fernandez – Guggenheim Andrew Baum – Citi Laura Sutcliffe – UBS Kerry Holford – Berenberg Presentation Operator Good afternoon, everyone and welcome to the analyst call on the GSK's Third Quarter 2021 Results. I will now hand you over to Nick Stone, Head of Investor Relations, who will introduce today's session. Nick
For further details see:
GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q3 2021 Results - Earnings Call Transcript